Table I.
Group | n | ALT (IU/l) | AST (IU/l) | Alb (g/l) | TBIL (umol/l) | DBIL (umol/l) | CHE (U/l) | ALP (IU/l) | GGT (IU/l) |
---|---|---|---|---|---|---|---|---|---|
Control | 20 | 33.67±2.16 | 132.83±2.85 | 37.38±1.11 | 0.95±0.19 | 0.3±0.14 | 56.33±5.32 | 87.13±0.61 | 1.00±0.00 |
Model week 1 | 10 | 61.40±5.32a | 148.8±3.19a | 34.82±0.26a | 1.88±0.38a | 0.6±0.16a | 50.88±0.40 | 114.32±3.06a | 1.15±0.04a |
Model week 2 | 10 | 80.29±37.63a | 164.00±12.32a,b | 32.27±2.39a,b | 2.97±1.40a | 0.83±0.42a | 45.79±0.99a,b | 138.00±7.23a,b | 1.31±0.18a |
Model week 3 | 10 | 104.20±4.66a | 318.00±27.06a,c | 27.12±0.29a,c | 3.20±0.26a | 1.16±0.43a | 38.74±0.32a,c | 164.72±3.15a,c | 1.61±0.04a,c |
Model week 4 | 10 | 138.25±9.32a,d | 484.75±89.46a,d | 20.60±0.32a,d | 3.83±0.49a,d | 1.65±0.21a | 35.75±6.40a | 183.75±2.50a,d | 1.80±0.59 |
Data are presented as the mean ± standard deviation.
P<0.05 vs. control
P<0.05 vs. model week 1
P<0.05 vs. model week 2
P<0.05 vs. model week 3. ALT, alanine aminotransferase; AST, aspartate aminotransferase; Alb, albumin; TBil, total bilirubin; DBil, direct bilirubin; CHE, cholinesterase; ALP, alkaline phosphatase; GGT, gamma-glutamyltranspeptidase.